menu search

kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

kymera therapeutics presents preclinical data demonstrating activity of kt-253, a selective heterobifunctional mdm2 degrader, in acute myeloid leukemia at the american society of hematology annual mee

A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL...

December 11, 2022, 3:00 pm

kymera therapeutics provides webcast information for december 14 investor event

Company to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline Company to Share Clinical Data from KT-474 Phase I Patient Coh...

December 1, 2022, 7:00 am

kymera: upcoming trial data will make or break the company

kymera has some critical trial data coming up this quarter. Other IRAK4 inhibitors have been having tro...

November 8, 2022, 11:46 am

kymera therapeutics, inc. (kymr) q3 2022 earnings call transcript

kymera Therapeutics, Inc. (NASDAQ:KYMR ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET C...

November 6, 2022, 1:27 am

kymera therapeutics, inc. (kymr) ceo nello mainolfi on q2 2022 results - earnings call transcript

kymera Therapeutics, Inc. (NASDAQ:KYMR ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Com...

August 10, 2022, 2:11 am

kymera therapeutics, inc. (kymr) ceo nello mainolfi on q1 2022 results - earnings call transcript

kymera Therapeutics, Inc. (NASDAQ:KYMR ) Q1 2022 Results Conference Call May 3, 2022 8:00 AM ET Company...

May 3, 2022, 6:12 pm

kymera therapeutics, inc. (kymr) reports q4 loss, lags revenue estimates

kymera Therapeutics, Inc. (KYMR) delivered earnings and revenue surprises of -83.33% and 27.78%, respec...

February 24, 2022, 11:35 am

kymera therapeutics, inc. (kymr) reports q4 loss, lags revenue estimates

kymera Therapeutics, Inc. (KYMR) delivered earnings and revenue surprises of -83.33% and 27.78%, respec...

February 24, 2022, 11:35 am

kymera therapeutics, inc. (kymr) reports q4 loss, lags revenue estimates

kymera Therapeutics, Inc. (KYMR) delivered earnings and revenue surprises of -83.33% and 27.78%, respec...

February 24, 2022, 11:35 am


Search within

Pages Search Results: